Foundayo® pill (orforglipron) is a once-daily oral medication specifically designed for chronic weight management in adults with obesity or overweight conditions. It is a GLP-1 receptor agonist that mimics the body’s natural hormones to reduce appetite, increase satiety, and promote sustainable weight loss — offering a convenient, non-injectable pill option taken once daily, with or without food.
Get Started
Foundayo (orforglipron) is an FDA-approved, once-daily oral GLP-1 receptor agonist used for chronic weight management in qualifying adults with obesity or overweight conditions.
Foundayo is taken once daily by mouth, with or without food. Swallow the tablet whole — do not break, crush, or chew. Take only one tablet per day as prescribed by your provider.
No. Foundayo should not be taken with other GLP-1 receptor agonists (including injectable or oral options). Always share your full medication list with your provider before starting treatment.
Foundayo is a non-peptide GLP-1 receptor agonist that helps reduce appetite and caloric intake, supporting sustainable weight loss when combined with a reduced-calorie diet and increased physical activity.
Many patients notice appetite changes within the first few weeks. Meaningful weight loss typically builds over several months with consistent use, diet, and activity. Individual results vary.
Fill out our simple online form about you health goals and medical history from the comfort of your home.
One of our leading doctors will review your form and determine if prescriptive treatment is right for you.
If prescribed your treatment will be shipped directly to you within 1-2 business days from our closest pharmacy hub.